TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biobact AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
23 |
| Financial expenses |
0
|
1
|
7 |
| Earnings before taxes |
5
|
-11
|
436 |
| EBITDA |
-13
|
-17
|
-129 |
| Total assets |
100
|
323
|
508 |
| Current assets |
75
|
197
|
508 |
| Current liabilities |
74
|
5
|
180 |
| Equity capital |
25
|
318
|
328 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
25.0%
|
98.5%
|
64.6% |
| Turnover per employee |
0
|
0
|
12 |
| Profit as a percentage of turnover | 1895.7% | ||
| Return on assets (ROA) |
5.0%
|
-3.1%
|
87.2% |
| Current ratio |
101.4%
|
3940.0%
|
282.2% |
| Return on equity (ROE) |
20.0%
|
-3.5%
|
132.9% |
| Change turnover |
0
|
-23
|
-92 |
| Change turnover % |
-100%
|
-80% | |
| Chg. No. of employees |
0
|
-1
|
-2 |
| Chg. No. of employees % |
0%
|
-50%
|
-50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.